KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Other Operating Expenses (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Other Operating Expenses readings, the most recent being $6.6 billion for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 7.28% to $6.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $26.8 billion, a 6.35% increase, with the full-year FY2025 number at $26.6 billion, up 4.33% from a year prior.
  • Other Operating Expenses hit $6.6 billion in Q1 2026 for Thermo Fisher Scientific, down from $7.2 billion in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $7.2 billion in Q4 2025 to a low of $6.1 billion in Q1 2025.
  • Median Other Operating Expenses over the past 5 years was $6.4 billion (2023), compared with a mean of $6.5 billion.
  • Biggest five-year swings in Other Operating Expenses: soared 36.25% in 2022 and later dropped 6.56% in 2024.
  • Thermo Fisher Scientific's Other Operating Expenses stood at $6.8 billion in 2022, then decreased by 5.13% to $6.5 billion in 2023, then rose by 1.25% to $6.6 billion in 2024, then rose by 9.61% to $7.2 billion in 2025, then dropped by 8.74% to $6.6 billion in 2026.
  • The last three reported values for Other Operating Expenses were $6.6 billion (Q1 2026), $7.2 billion (Q4 2025), and $6.5 billion (Q3 2025) per Business Quant data.